$KLIC
Kulicke and Soffa Industries Inc Stock $klic

$klic Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000005697822000054 Filed on May 05, 2022

Income Statement

Concept	2022 Q2	2021 Q2
Revenue	$384.3M	$340.2M
YoY Change	12.97%	126.1%
Cost Of Revenue	$182.6M	$191.7M
YoY Change	-4.75%	136.55%
Gross Profit	$201.7M	$148.5M
YoY Change	35.84%	113.89%
Gross Profit Margin	52.49%	43.65%
Selling, General & Admin	$35.09M	$30.51M
YoY Change	15.01%	9.33%
% of Gross Profit	17.4%	20.55%
Research & Development	$37.28M	$34.87M
YoY Change	6.92%	14.15%
% of Gross Profit	18.48%	23.48%
Depreciation & Amortization	$4.073M	$3.245M
YoY Change	25.52%	-0.31%
% of Gross Profit	2.02%	2.19%
Operating Expenses	$72.37M	$65.38M
YoY Change	10.7%	11.85%
Operating Profit	$129.3M	$83.11M
YoY Change	55.62%	657.58%
Interest Expense	$97.00K	$74.00K
YoY Change	31.08%	-83.41%
% of Operating Profit	0.07%	0.09%
Other Income/Expense, Net
YoY Change
Pretax Income	$129.7M	$83.63M
YoY Change	55.11%	602.8%
Income Tax	$13.71M	$12.21M
% Of Pretax Income	10.57%	14.6%
Net Earnings	$116.0M	$71.32M
YoY Change	62.65%	539.58%
Net Earnings / Revenue	30.19%	20.97%
Basic Earnings Per Share	$1.89	$1.15
Diluted Earnings Per Share	$1.86	$1.13
COMMON SHARES
Basic Shares Outstanding	61.48M shares	62.07M shares
Diluted Shares Outstanding	62.44M shares	63.24M shares

Balance Sheet

Concept	2022 Q2	2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$690.5M	$564.3M
YoY Change	22.36%	9.4%
Cash & Equivalents	$460.5M	$257.3M
Short-Term Investments	$300.0M	$307.0M
Other Short-Term Assets	$51.43M	$23.50M
YoY Change	118.86%	71.53%
Inventory	$211.9M	$140.0M
Prepaid Expenses
Receivables	$368.1M	$307.9M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.322B	$1.036B
YoY Change	27.63%	23.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$67.04M	$61.97M
YoY Change	8.2%	11.0%
Goodwill	$71.47M	$73.55M
YoY Change	-2.83%	31.21%
Intangibles	$38.44M	$46.05M
YoY Change	-16.52%	20.52%
Long-Term Investments	$6.417M	$0.00
YoY Change		-100.0%
Other Assets	$2.428M	$2.292M
YoY Change	5.93%	8.52%
Total Long-Term Assets	$237.1M	$221.2M
YoY Change	7.19%	16.27%
TOTAL ASSETS
Total Short-Term Assets	$1.322B	$1.036B
Total Long-Term Assets	$237.1M	$221.2M
Total Assets	$1.559B	$1.257B
YoY Change	24.03%	22.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$100.2M	$123.8M
YoY Change	-19.07%	149.36%
Accrued Expenses	$49.99M	$47.10M
YoY Change	6.14%	0.21%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$274.9M	$259.6M
YoY Change	5.9%	81.77%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$15.11M	$13.17M
YoY Change	14.74%	30.69%
Total Long-Term Liabilities	$15.11M	$13.17M
YoY Change	14.74%	30.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$274.9M	$259.6M
Total Long-Term Liabilities	$15.11M	$13.17M
Total Liabilities	$421.8M	$390.1M
YoY Change	8.11%	39.42%
SHAREHOLDERS EQUITY
Retained Earnings	$1.177B	$718.4M
YoY Change	63.89%	18.21%
Common Stock	$522.9M	$542.1M
YoY Change	-3.55%	1.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$554.7M	$392.7M
YoY Change	41.26%	1.39%
Treasury Stock Shares	25.90M shares	23.30M shares
Shareholders Equity	$1.137B	$866.9M
YoY Change
Total Liabilities & Shareholders Equity	$1.559B	$1.257B
YoY Change	24.03%	22.1%

Cashflow Statement

Concept	2022 Q2	2021 Q2
OPERATING ACTIVITIES
Net Income	$116.0M	$71.32M
YoY Change	62.65%	539.58%
Depreciation, Depletion And Amortization	$4.073M	$3.245M
YoY Change	25.52%	-0.31%
Cash From Operating Activities	$73.13M	$27.10M
YoY Change	169.87%	14.83%
INVESTING ACTIVITIES
Capital Expenditures	-$2.947M	-$4.000M
YoY Change	-26.33%	29.03%
Acquisitions
YoY Change
Other Investing Activities	$137.1M	$5.800M
YoY Change	2264.12%	-89.26%
Cash From Investing Activities	$134.2M	$1.800M
YoY Change	7354.0%	-96.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-187.0M	-9.900M
YoY Change	1788.76%	-93.17%
NET CHANGE
Cash From Operating Activities	73.13M	27.10M
Cash From Investing Activities	134.2M	1.800M
Cash From Financing Activities	-187.0M	-9.900M
Net Change In Cash	20.32M	19.00M
YoY Change	6.95%	-126.99%
FREE CASH FLOW
Cash From Operating Activities	$73.13M	$27.10M
Capital Expenditures	-$2.947M	-$4.000M
Free Cash Flow	$76.08M	$31.10M
YoY Change	144.64%	16.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Period End Date DocumentPeriodEndDate	2022-04-02
	dei	Entity Central Index Key EntityCentralIndexKey	0000056978
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-01
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-04-02
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-121
	dei	Entity Registrant Name EntityRegistrantName	KULICKE AND SOFFA INDUSTRIES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	PA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-1498399
	dei	Entity Address Address Line1 EntityAddressAddressLine1	23A Serangoon North Avenue 5
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#01-01,
	dei	Entity Address City Or Town EntityAddressCityOrTown	Singapore
	dei	Entity Address Country EntityAddressCountry	SG
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	554369
	dei	City Area Code CityAreaCode	215
	dei	Local Phone Number LocalPhoneNumber	784-6000
	dei	Security12b Title Security12bTitle	Common Stock, Without Par Value
	dei	Trading Symbol TradingSymbol	KLIC
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	59130119	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	460453000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	362788000	USD
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	230000000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	377000000	USD
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	687000	USD
CY2022Q2	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	368101000	USD
CY2021Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	421193000	USD
CY2022Q2	us-gaap	Inventory Net InventoryNet	211877000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	167323000	USD
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	51431000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	23586000	USD
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1321862000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1351890000	USD
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67044000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67982000	USD
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38029000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41592000	USD
CY2022Q2	us-gaap	Goodwill Goodwill	71468000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	72949000	USD
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	38440000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	42752000	USD
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	13319000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15715000	USD
CY2022Q2	us-gaap	Equity Securities Fv Ni And Without Readily Determinable Fair Value EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue	6417000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni And Without Readily Determinable Fair Value EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue	6388000	USD
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2428000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2363000	USD
CY2022Q2	us-gaap	Assets Assets	1559007000	USD
CY2021Q4	us-gaap	Assets Assets	1601631000	USD
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	100213000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	154636000	USD
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4932000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4903000	USD
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	33101000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	30766000	USD
CY2022Q2	klic	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	136643000	USD
CY2021Q4	klic	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	161570000	USD
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	274889000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	351875000	USD
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	34016000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	32828000	USD
CY2022Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	63050000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	69422000	USD
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34688000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	38084000	USD
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15112000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14185000	USD
CY2022Q2	us-gaap	Liabilities Liabilities	421755000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	506394000	USD
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85364000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85364000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59468000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61931000	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	522864000	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	23433000	shares
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	554684000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	550117000	USD
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	25896000	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	400412000	USD
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1177441000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	948554000	USD
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8369000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3022000	USD
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1137252000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1095237000	USD
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1559007000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1601631000	USD
CY2022Q2	us-gaap	Revenues Revenues	384282000	USD
CY2021Q2	us-gaap	Revenues Revenues	340163000	USD
	us-gaap	Revenues Revenues	845170000	USD
	us-gaap	Revenues Revenues	608020000	USD
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	182572000	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	191673000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	420222000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	338044000	USD
CY2022Q2	us-gaap	Gross Profit GrossProfit	201710000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	148490000	USD
	us-gaap	Gross Profit GrossProfit	424948000	USD
	us-gaap	Gross Profit GrossProfit	269976000	USD
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35088000	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30508000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	74047000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	66408000	USD
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	37281000	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34868000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	70450000	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	65376000	USD
	us-gaap	Operating Expenses OperatingExpenses	144497000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63118000	shares
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	66412000	USD
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	72369000	USD
	us-gaap	Operating Expenses OperatingExpenses	132820000	USD
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	129341000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	83114000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	280451000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	137156000	USD
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	470000	USD
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	586000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	941000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1237000	USD
CY2022Q2	us-gaap	Interest Expense InterestExpense	97000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	74000	USD
	us-gaap	Interest Expense InterestExpense	137000	USD
	us-gaap	Interest Expense InterestExpense	106000	USD
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	129714000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	83626000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	281255000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	138287000	USD
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13713000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12212000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31648000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18510000	USD
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-94000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-94000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	116001000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	71320000	USD
	us-gaap	Net Income Loss NetIncomeLoss	249607000	USD
	us-gaap	Net Income Loss NetIncomeLoss	119683000	USD
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.89
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.93
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.86
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.97
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.90
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61482000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62068000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61934000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62023000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62435000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63237000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62907000	shares
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1986000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	116001000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	71320000	USD
	us-gaap	Net Income Loss NetIncomeLoss	249607000	USD
	us-gaap	Net Income Loss NetIncomeLoss	119683000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-4351000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-5200000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-6016000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-49000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-219000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	19000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-80000	USD
CY2022Q2	klic	Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent	-4302000	USD
CY2021Q2	klic	Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent	-4981000	USD
	klic	Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent	-6035000	USD
	klic	Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent	2066000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4358000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6241000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5347000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1522000	USD
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	111643000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	65079000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	244260000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	121205000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1095237000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	238000	USD
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	15380000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5074000	USD
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	10610000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	133606000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-989000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	132617000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1207176000	USD
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	237000	USD
CY2022Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	176153000	USD
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4459000	USD
CY2022Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	10110000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	116001000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4358000	USD
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	111643000	USD
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1137252000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	757994000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	173000	USD
CY2021Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1206000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3216000	USD
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8687000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	48363000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7763000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	56126000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	807616000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	185000	USD
CY2021Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1110000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3778000	USD
CY2021Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8688000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	71320000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6241000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	65079000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	866860000	USD
	us-gaap	Net Income Loss NetIncomeLoss	249607000	USD
	us-gaap	Net Income Loss NetIncomeLoss	119683000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10563000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9748000	USD
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	10008000	USD
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	7364000	USD
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	1046000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-245000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-18000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	-140000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	1136000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3584000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3169000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	98000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	14000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	1412000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-193000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-94000	USD
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-53430000	USD
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	109329000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	44367000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29307000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	27205000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4390000	USD
	klic	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-81318000	USD
	klic	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	94259000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-4042000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-80000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-644000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-596000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	169009000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	85720000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	26338000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5658000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8899000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	119000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	121000	USD
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	2115000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	319000000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	140000000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	466000000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	175000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	141461000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1999000	USD
	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	54500000	USD
	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	22750000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	54500000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	22750000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	242000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	164000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	191539000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2866000	USD
	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	19283000	USD
	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	16087000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-211064000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19117000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1741000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	604000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	97665000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	69206000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	362788000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188127000	USD
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	460453000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	257333000	USD
	us-gaap	Interest Paid Net InterestPaidNet	137000	USD
	us-gaap	Interest Paid Net InterestPaidNet	106000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	32856000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	21585000	USD
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (“we,” “us,” “our,” or the “Company”) with appropriate elimination of intercompany balances and transactions. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim consolidated condensed financial statements are unaudited and, in management's opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair presentation of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended October 2, 2021, filed with the Securities and Exchange Commission, which includes Consolidated Balance Sheets as of October 2, 2021 and October 3, 2020, and the related Consolidated Statements of Operations, Statements of Comprehensive Income, Changes in Shareholders' Equity and Cash Flows for each of the years in the three-year period ended October 2, 2021. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company's first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2022 quarters end on January 1, 2022, April 2, 2022, July 2, 2022 and October 1, 2022. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2021 quarters ended on January 2, 2021, April 3, 2021, July 3, 2021 and October 2, 2021. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designs, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company's operating results depend upon the capital and operating expenditures of semiconductor device manufacturers, integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), and other electronics manufacturers including automotive electronics suppliers worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry's demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, including those sold by the Company. These downturns and slowdowns have in the past adversely affected the Company's operating results. The Company believes such volatility will continue to characterize the industry and the Company's operations in the future.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company's assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the coronavirus (“COVID-19”) pandemic, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of April 2, 2022. While there was no material impact to our consolidated condensed financial statements as of and for the quarter ended April 2, 2022, these estimates may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 that could materially impact our consolidated condensed financial statements in future reporting periods.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for the accounting policies for contract assets and accelerated share repurchases described below, there have been no material changes to our significant accounting policies summarized in Note 1 "Basis of Presentation" to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended October 2, 2021. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A contract asset is the Company’s right to consideration in exchange for goods or services that the Company has transferred to a customer. ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, distinguishes between a contract asset and a receivable based on whether receipt of the consideration is conditional on something other than the passage of time. When the Company transfers control of goods or services to a customer before the customer pays consideration, the Company records either a contract asset or a receivable depending on the nature of the Company’s right to consideration for its performance. The point at which a contract asset becomes an account receivable may be earlier than the point at which an invoice is issued. The Company assesses a contract asset for impairment in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accelerated Share Repurchase </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may enter into accelerated share repurchase (“ASR”) agreements with third-party financial institutions to repurchase shares of the Company’s common stock. Under an ASR agreement, in exchange for an up-front payment, the counterparty makes an initial delivery of shares of the Company's common stock during the purchase period of the relevant ASR. This initial delivery of shares represents the minimum number of shares that the Company may receive under an ASR agreement. Upon settlement of an ASR agreement, the counterparty may deliver additional shares, with the final number of shares delivered determined based on the volume-weighted average price of the Company’s common stock over the term of such ASR agreement, less an agreed-upon discount. The transactions are accounted for as equity transactions and are included in Treasury Stock when the shares are received, at which time there is an immediate reduction in the weighted-average common shares calculation for basic and diluted earnings per share. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and clarify and amend existing guidance. We adopted this ASU in the first quarter of fiscal 2022. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts in Entity's Own Equity</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging - Contracts in Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 815). The amendments in this ASU, among other changes, remove current guidance that allows an entity to rebut the presumption that potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares if the entity has a history or policy of cash settlement. These amendments affect any instrument that may be settled in cash or shares and, therefore, affects the diluted earnings per share calculation for both convertible instruments and contracts in an entity's own equity. We elected to early adopt this ASU in the second quarter of fiscal 2022. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this ASU affect a wide variety of Topics in the Codification and improve the consistency of the Codification by including all disclosure guidance in the appropriate disclosure section (Section 50). We adopted this ASU in the first quarter of fiscal 2022. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.</span></div>
	us-gaap	Fiscal Period FiscalPeriod	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span>Each of the Company's first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2022 quarters end on January 1, 2022, April 2, 2022, July 2, 2022 and October 1, 2022. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2021 quarters ended on January 2, 2021, April 3, 2021, July 3, 2021 and October 2, 2021.
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company's assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the coronavirus (“COVID-19”) pandemic, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of April 2, 2022. While there was no material impact to our consolidated condensed financial statements as of and for the quarter ended April 2, 2022, these estimates may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 that could materially impact our consolidated condensed financial statements in future reporting periods.</span></div>
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	230000000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	377000000	USD
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	117864000	USD
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	94493000	USD
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	70649000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	55866000	USD
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	44475000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	40006000	USD
CY2022Q2	us-gaap	Inventory Gross InventoryGross	232988000	USD
CY2021Q4	us-gaap	Inventory Gross InventoryGross	190365000	USD
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	21111000	USD
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	23042000	USD
CY2022Q2	us-gaap	Inventory Net InventoryNet	211877000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	167323000	USD
CY2022Q2	us-gaap	Land Land	2182000	USD
CY2021Q4	us-gaap	Land Land	2182000	USD
CY2022Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	23464000	USD
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	23314000	USD
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	32057000	USD
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	30054000	USD
CY2022Q2	klic	Equipment And Software Gross EquipmentAndSoftwareGross	41419000	USD
CY2021Q4	klic	Equipment And Software Gross EquipmentAndSoftwareGross	40945000	USD
CY2022Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	93421000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	87994000	USD
CY2022Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	8419000	USD
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	9562000	USD
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	200962000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	194051000	USD
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	133918000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	126069000	USD
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67044000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67982000	USD
CY2022Q2	srt	Payables To Customers PayablesToCustomers	76245000	USD
CY2021Q4	srt	Payables To Customers PayablesToCustomers	72478000	USD
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	38966000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	66531000	USD
CY2022Q2	klic	Accrued Liabilities For Commission And Professional Fees Current AccruedLiabilitiesForCommissionAndProfessionalFeesCurrent	10110000	USD
CY2021Q4	klic	Accrued Liabilities For Commission And Professional Fees Current AccruedLiabilitiesForCommissionAndProfessionalFeesCurrent	8673000	USD
CY2022Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	6093000	USD
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	6190000	USD
CY2022Q2	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	0	USD
CY2021Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	31000	USD
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5229000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7667000	USD
CY2022Q2	klic	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	136643000	USD
CY2021Q4	klic	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	161570000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	72949000	USD
	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-1481000	USD
CY2022Q2	us-gaap	Goodwill Goodwill	71468000	USD
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	38440000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	42752000	USD
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2641000	USD
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5980000	USD
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5980000	USD
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5980000	USD
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5980000	USD
CY2022Q2	klic	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	11879000	USD
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	38440000	USD
CY2022Q2	us-gaap	Cash Cash	176750000	USD
CY2022Q2	klic	Cash Unrealized Gains CashUnrealizedGains	0	USD
CY2022Q2	klic	Cash Unrealized Losses CashUnrealizedLosses	0	USD
CY2022Q2	klic	Cash Estimated Fair Value CashEstimatedFairValue	176750000	USD
CY2022Q2	klic	Cashand Cash Equivalents Amortized Cost CashandCashEquivalentsAmortizedCost	460473000	USD
CY2022Q2	klic	Cashand Cash Equivalents Gross Unrealized Gain CashandCashEquivalentsGrossUnrealizedGain	0	USD
CY2022Q2	klic	Cashand Cash Equivalents Gross Unrealized Loss CashandCashEquivalentsGrossUnrealizedLoss	20000	USD
CY2022Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	460453000	USD
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	230000000	USD
CY2022Q2	klic	Availableforsale Securities Shortterm Investments Gross Unrealized Gain AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedGain	0	USD
CY2022Q2	klic	Availableforsale Securities Shortterm Investments Gross Unrealized Loss AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedLoss	0	USD
CY2022Q2	klic	Availableforsale Securities Shortterm Investments Fair Value Disclosure AvailableforsaleSecuritiesShorttermInvestmentsFairValueDisclosure	230000000	USD
CY2022Q2	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestments	690473000	USD
CY2022Q2	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Gain CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedGain	0	USD
CY2022Q2	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Loss CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedLoss	20000	USD
CY2022Q2	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Fair Value Disclosure CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsFairValueDisclosure	690453000	USD
CY2021Q4	us-gaap	Cash Cash	269201000	USD
CY2021Q4	klic	Cash Unrealized Gains CashUnrealizedGains	0	USD
CY2021Q4	klic	Cash Unrealized Losses CashUnrealizedLosses	0	USD
CY2021Q4	klic	Cash Estimated Fair Value CashEstimatedFairValue	269201000	USD
CY2021Q4	klic	Cashand Cash Equivalents Amortized Cost CashandCashEquivalentsAmortizedCost	362806000	USD
CY2021Q4	klic	Cashand Cash Equivalents Gross Unrealized Gain CashandCashEquivalentsGrossUnrealizedGain	0	USD
CY2021Q4	klic	Cashand Cash Equivalents Gross Unrealized Loss CashandCashEquivalentsGrossUnrealizedLoss	18000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	362788000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	377000000	USD
CY2021Q4	klic	Availableforsale Securities Shortterm Investments Gross Unrealized Gain AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedGain	0	USD
CY2021Q4	klic	Availableforsale Securities Shortterm Investments Gross Unrealized Loss AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedLoss	0	USD
CY2021Q4	klic	Availableforsale Securities Shortterm Investments Fair Value Disclosure AvailableforsaleSecuritiesShorttermInvestmentsFairValueDisclosure	377000000	USD
CY2021Q4	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestments	739806000	USD
CY2021Q4	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Gain CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedGain	0	USD
CY2021Q4	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Loss CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedLoss	18000	USD
CY2021Q4	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Fair Value Disclosure CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsFairValueDisclosure	739788000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	52186000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	12566000	USD
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	39620000	USD
CY2022Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	49746000	USD
CY2022Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	72000	USD
CY2021Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	57682000	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	616000	USD
	us-gaap	Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1 DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1	P12M
	klic	Leases Numberof Options To Extend LeasesNumberofOptionsToExtend	0	extend_options
CY2022Q2	us-gaap	Lease Cost LeaseCost	1990000	USD
CY2021Q2	us-gaap	Lease Cost LeaseCost	1932000	USD
	us-gaap	Lease Cost LeaseCost	4044000	USD
	us-gaap	Lease Cost LeaseCost	3799000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	3752000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	3558000	USD
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y2M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y7M6D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.058
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.058
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	3719000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6697000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6247000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5863000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5013000	USD
CY2022Q2	klic	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	24647000	USD
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4932000	USD
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34688000	USD
CY2022Q2	us-gaap	Pension Contributions PensionContributions	496000	USD
CY2022Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	6417000	USD
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	6388000	USD
CY2022Q2	us-gaap	Equity Securities Fv Ni And Without Readily Determinable Fair Value EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue	6417000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni And Without Readily Determinable Fair Value EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue	6388000	USD
CY2021Q2	us-gaap	Pension Contributions PensionContributions	447000	USD
	us-gaap	Pension Contributions PensionContributions	1004000	USD
	us-gaap	Pension Contributions PensionContributions	866000	USD
CY2017Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	USD
CY2018Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	200000000	USD
CY2019Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	USD
CY2020Q3	klic	Stock Repurchase Program Authorized Amount Additional Amount StockRepurchaseProgramAuthorizedAmountAdditionalAmount	400000000	USD
CY2022Q1	klic	Stock Repurchase Program Authorized Amount Additional Amount StockRepurchaseProgramAuthorizedAmountAdditionalAmount	400000000	USD
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	800000000	USD
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	800000000	USD
CY2021Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.17
CY2022Q2	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	10600000	USD
	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	19300000	USD
	klic	Relative Total Shareholder Return Average Stock Price Calculation Period RelativeTotalShareholderReturnAverageStockPriceCalculationPeriod	P90D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	18000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	15000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	541000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	704000	shares
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4696000	USD
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3963000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10008000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7364000	USD
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4696000	USD
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3963000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10008000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7364000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2022Q2	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	26721000	USD
CY2021Q2	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	USD
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	26721000	USD
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	USD
CY2022Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	26721000	USD
CY2021Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2022Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	26721000	USD
CY2021Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	28228000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4212000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	15596000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2958000	USD
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-43818000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-10418000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-75184000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-20268000	USD
CY2022Q2	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress	32890000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress	11994000	USD
	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress	76888000	USD
	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress	23098000	USD
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	17300000	USD
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5788000	USD
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	17300000	USD
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5788000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	116001000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	116001000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	71320000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	71320000	USD
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61482000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61482000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62068000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62068000	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	953000	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1169000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62435000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63237000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.89
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.89
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.15
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.15
CY2022Q2	klic	Earnings Per Share Diluted Adjustment EarningsPerShareDilutedAdjustment	-0.03
CY2021Q2	klic	Earnings Per Share Diluted Adjustment EarningsPerShareDilutedAdjustment	-0.02
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.86
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.13
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21000	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Net Income Loss NetIncomeLoss	249607000	USD
	us-gaap	Net Income Loss NetIncomeLoss	249607000	USD
	us-gaap	Net Income Loss NetIncomeLoss	119683000	USD
	us-gaap	Net Income Loss NetIncomeLoss	119683000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61934000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61934000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62023000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62023000	shares
	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	973000	USD
	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	1095000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62907000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63118000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.93
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.93
	klic	Earnings Per Share Diluted Adjustment EarningsPerShareDilutedAdjustment	-0.06
	klic	Earnings Per Share Diluted Adjustment EarningsPerShareDilutedAdjustment	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.97
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.90
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3000	shares
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13713000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12212000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31648000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18510000	USD
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.106
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.146
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.113
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.134
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q2	us-gaap	Revenues Revenues	384282000	USD
CY2021Q2	us-gaap	Revenues Revenues	340163000	USD
	us-gaap	Revenues Revenues	845170000	USD
	us-gaap	Revenues Revenues	608020000	USD
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	129341000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	83114000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	280451000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	137156000	USD
CY2022Q2	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	3384000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	5121000	USD
	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	6260000	USD
	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	8808000	USD
CY2022Q2	us-gaap	Depreciation Depreciation	4073000	USD
CY2021Q2	us-gaap	Depreciation Depreciation	3245000	USD
	us-gaap	Depreciation Depreciation	8129000	USD
	us-gaap	Depreciation Depreciation	6434000	USD
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1151000	USD
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1355000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2434000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3313000	USD
	klic	Period Of Warranty For Manufacturing Defects PeriodOfWarrantyForManufacturingDefects	P1Y
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	17110000	USD
CY2021Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	12136000	USD
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	16961000	USD
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	9576000	USD
CY2022Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	2191000	USD
CY2021Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	6029000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	6159000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	11329000	USD
CY2021Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2591000	USD
CY2022Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	3783000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	7602000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5331000	USD
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	15518000	USD
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	15574000	USD
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	15518000	USD
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	15574000	USD
CY2022Q2	klic	Inventory Purchase Obligation Future Minimum Payments Due InventoryPurchaseObligationFutureMinimumPaymentsDue	412385000	USD
CY2022Q2	klic	Inventory Purchase Obligation Future Minimum Payments Due Current InventoryPurchaseObligationFutureMinimumPaymentsDueCurrent	76877000	USD
CY2022Q2	klic	Inventory Purchase Obligation Future Minimum Payments Due In Two Years InventoryPurchaseObligationFutureMinimumPaymentsDueInTwoYears	335508000	USD
CY2022Q2	klic	Inventory Purchase Obligation Future Minimum Payments Due In Three Years InventoryPurchaseObligationFutureMinimumPaymentsDueInThreeYears	0	USD
CY2022Q2	klic	Inventory Purchase Obligation Future Minimum Payments Due In Four Years InventoryPurchaseObligationFutureMinimumPaymentsDueInFourYears	0	USD
CY2022Q2	klic	Inventory Purchase Obligation Future Minimum Payments Due In Five Years InventoryPurchaseObligationFutureMinimumPaymentsDueInFiveYears	0	USD
CY2022Q2	klic	Inventory Purchase Obligation Future Minimum Payments Due Thereafter InventoryPurchaseObligationFutureMinimumPaymentsDueThereafter	0	USD

Files In Submission

Name	View Source	Status
0000056978-22-000054-index-headers.html	Edgar Link	pending
0000056978-22-000054-index.html	Edgar Link	pending
0000056978-22-000054.txt	Edgar Link	pending
0000056978-22-000054-xbrl.zip	Edgar Link	pending
a10qq22022ex311.htm	Edgar Link	pending
a10qq22022ex312.htm	Edgar Link	pending
a10qq22022ex321.htm	Edgar Link	pending
a10qq22022ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
klic-20220402.htm	Edgar Link	pending
klic-20220402.xsd	Edgar Link	pending
klic-20220402_cal.xml	Edgar Link	unprocessable
klic-20220402_def.xml	Edgar Link	unprocessable
klic-20220402_htm.xml	Edgar Link	completed
klic-20220402_lab.xml	Edgar Link	unprocessable
klic-20220402_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KLIC
Kulicke and Soffa Industries Inc Stock $klic

2022 Q2 Form 10-Q Financial Statement

#000005697822000054 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KLIC Kulicke and Soffa Industries Inc Stock $klic

2022 Q2 Form 10-Q Financial Statement

#000005697822000054 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KLIC
Kulicke and Soffa Industries Inc Stock $klic